These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18810601)

  • 1. Handwriting as a gauge of cognitive status: a novel forensic tool for posthumous evaluation of testamentary capacity.
    Fontana P; Dagnino F; Cocito L; Balestrino M
    Neurol Sci; 2008 Sep; 29(4):257-61. PubMed ID: 18810601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of testamentary capacity and vulnerability to undue influence.
    Shulman KI; Cohen CA; Kirsh FC; Hull IM; Champine PR
    Am J Psychiatry; 2007 May; 164(5):722-7. PubMed ID: 17475729
    [No Abstract]   [Full Text] [Related]  

  • 3. Testamentary capacity and guardianship assessments.
    Roof JG
    Psychiatr Clin North Am; 2012 Dec; 35(4):915-27. PubMed ID: 23107570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testamentary Capacity Assessment Tool (TCAT): A Brief Instrument for Patients with Dementia.
    Papageorgiou SG; Voskou P; Economou A; Beratis I; Douzenis A
    J Alzheimers Dis; 2018; 61(3):985-994. PubMed ID: 29254082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered handwriting suggests cognitive impairment and may be relevant to posthumous evaluation.
    Balestrino M; Fontana P; Terzuoli S; Volpe S; Inglese ML; Cocito L
    J Forensic Sci; 2012 Sep; 57(5):1252-8. PubMed ID: 22515315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advanced investigation of testamentary capacity of the mentally disordered].
    Pang YX; Cai WX; Zhang QT; Huang FY; Tang T; Wu JS; Wang JJ; Dong RX
    Fa Yi Xue Za Zhi; 2009 Jun; 25(3):208-11. PubMed ID: 19697782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of legal capacity and testamentary capacity].
    Dreßing H; Foerster K; Leygraf J; Schneider F
    Nervenarzt; 2014 Nov; 85(11):1441-50; quiz 1451-2. PubMed ID: 25256794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment assessment through handwriting (COGITAT) score: a novel tool that predicts cognitive state from handwriting for forensic and clinical applications.
    Balestrino M; Brugnolo A; Girtler N; Pardini M; Rizzetto C; Alì PA; Cocito L; Schiavetti I
    Front Psychol; 2024; 15():1275315. PubMed ID: 38605845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial and testamentary capacity evaluations: procedures and assessment instruments underneath a functional approach.
    Sousa LB; Simões MR; Firmino H; Peisah C
    Int Psychogeriatr; 2014 Feb; 26(2):217-28. PubMed ID: 24229806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological autopsy of testamentary capacity: Methodology and issues in the elderly.
    Zago S; Bolognini N
    Appl Neuropsychol Adult; 2022; 29(4):570-583. PubMed ID: 32687452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A short neuropsychologic and cognitive evaluation of frontotemporal dementia.
    Valverde AH; Jimenez-Escrig A; Gobernado J; Barón M
    Clin Neurol Neurosurg; 2009 Apr; 111(3):251-5. PubMed ID: 19062159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Language performance in Alzheimer's disease and mild cognitive impairment: a comparative review.
    Taler V; Phillips NA
    J Clin Exp Neuropsychol; 2008 Jul; 30(5):501-56. PubMed ID: 18569251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Spanish version of Addenbrooke's Cognitive Examination III for diagnosing dementia.
    Matias-Guiu JA; Fernández de Bobadilla R; Escudero G; Pérez-Pérez J; Cortés A; Morenas-Rodríguez E; Valles-Salgado M; Moreno-Ramos T; Kulisevsky J; Matías-Guiu J
    Neurologia; 2015; 30(9):545-51. PubMed ID: 25002342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing capacity to consent to treatment with cholinesterase inhibitors in dementia using a specific and standardized version of the MacArthur Competence Assessment Tool (MacCAT-T).
    Mueller T; Haberstroh J; Knebel M; Oswald F; Kaspar R; Kemper CJ; Halder-Sinn P; Schroeder J; Pantel J
    Int Psychogeriatr; 2017 Feb; 29(2):333-343. PubMed ID: 27825402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical reasons for retrospective challenges of testamentary capacity.
    Jovanović AA; Jovović S; Milovanović S; Jasović-Gasić M
    Psychiatr Danub; 2008 Dec; 20(4):485-93. PubMed ID: 19011589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping dementia and cognitive decline in testamentary capacity.
    Purser K; Lonie J
    Int J Law Psychiatry; 2019; 66():101450. PubMed ID: 31706409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cut-off scores in MMSE: a moving target?
    Morgado J; Rocha CS; Maruta C; Guerreiro M; Martins IP
    Eur J Neurol; 2010 May; 17(5):692-5. PubMed ID: 20050900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development and validation of a carer questionnaire to assess cognitive function in neuropsychiatric patients.
    Randhawa S; Walterfang M; Miller K; Scholes A; Mocellin R; Velakoulis D
    J Psychosom Res; 2007 Jul; 63(1):93-8. PubMed ID: 17586342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric issues in retrospective challenges of testamentary capacity.
    Shulman KI; Cohen CA; Hull I
    Int J Geriatr Psychiatry; 2005 Jan; 20(1):63-9. PubMed ID: 15578664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common pitfalls in the evaluation of testamentary capacity.
    Gutheil TG
    J Am Acad Psychiatry Law; 2007; 35(4):514-7. PubMed ID: 18086745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.